Arris J. Henderson
- Molecular Biology
- Oncology top 10%
- Radiology, Nuclear Medicine and Imaging top 5%
- Cancer Research top 10%
- Hepatology top 5%
- Co-authors
- Pamela A. TrailDavid WillnerShirley J. LaschIngegerd HellströmAnna Maria CasazzaRaymond A. FirestoneSandra J. HofsteadK E Hellström
- Topics
- Peptidase Inhibition and Analysis (3 papers)Monoclonal and Polyclonal Antibodies Research (3 papers)Click Chemistry and Applications (2 papers)
- Partner nations
- United StatesGermanySwitzerland
In The Last Decade
Arris J. Henderson
8 papers receiving 1.0k citations
Peers
Comparison fields: 5 of 75
- Molecular Biology 454
- Oncology 424
- Radiology, Nuclear Medicine and Imaging 320
- Cancer Research 186
- Hepatology 177
Countries citing papers authored by Arris J. Henderson
This map shows the geographic impact of Arris J. Henderson's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Arris J. Henderson with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Arris J. Henderson more than expected).
Fields of papers citing papers by Arris J. Henderson
This network shows the impact of papers produced by Arris J. Henderson. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Arris J. Henderson. The network helps show where Arris J. Henderson may publish in the future.
Co-authorship network of co-authors of Arris J. Henderson
This figure shows the co-authorship network connecting the top 25 collaborators of Arris J. Henderson. A scholar is included among the top collaborators of Arris J. Henderson based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Arris J. Henderson. Arris J. Henderson is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | Analysis of transcription and protein expression changes in the 786-O human renal cell carcinoma tumor xenograft model in response to treatment with the multi-kinase inhibitor sorafenib (BAY 43-9006) | 25 |
| 2 | 388 | |
| 3 | Inhibition of angiogenesis and metastasis in two murine models by the matrix metalloproteinase inhibitor, BMS-275291. | 89 |
| 4 | Enhanced antitumor activity of paclitaxel in combination with the anticarcinoma immunoconjugate BR96-doxorubicin. | 32 |
| 5 | 25 | |
| 6 | Effect of linker variation on the stability, potency, and efficacy of carcinoma-reactive BR64-doxorubicin immunoconjugates. | 45 |
| 7 | 27 | |
| 8 | 414 |
About Arris J. Henderson
Arris J. Henderson is a scholar working on Biotechnology, Cancer Research and Oncology, having authored 8 papers that have together received 1.0k indexed citations. Recurring topics across this work include Peptidase Inhibition and Analysis (3 papers), Monoclonal and Polyclonal Antibodies Research (3 papers) and Click Chemistry and Applications (2 papers). The work is most often cited by research in Hepatology (177 citations), Oncology (424 citations) and Radiology, Nuclear Medicine and Imaging (320 citations). Arris J. Henderson has collaborated with scholars based in United States, Germany and Switzerland. Frequent co-authors include Pamela A. Trail, David Willner, Shirley J. Lasch, Ingegerd Hellström, Anna Maria Casazza, Raymond A. Firestone, Sandra J. Hofstead, K E Hellström, Joan Levy and Yong S. Chang. Their work appears in journals such as Science, Cancer Research and Journal of Controlled Release.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.